GLP-1 receptor agonist initiation and risk of psychiatric hospitalisation and emergency department presentation in adults with schizophrenia and type 2 diabetes in the USA: an observational cohort study using electronic health records data.
The lancet. Psychiatry · 2026
Abstract e pubblicazione originale
L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.
Leggi nella fonte originale ↗Parole chiave
AdultFemaleHumansMaleMiddle AgedAntipsychotic AgentsCohort StudiesDiabetes Mellitus, Type 2Dipeptidyl-Peptidase IV InhibitorsElectronic Health RecordsEmergency Room VisitsEmergency Service, HospitalGlucagon-Like Peptide-1 Receptor AgonistsHospitalizationSchizophreniaSodium-Glucose Transporter 2 InhibitorsUnited States
Come citare questo studio
Najmeh Davoodian, Lana J Williams, Michael Berk, Urska Arnautovska, Jee Hyun Kim, James McLure, Bruna Panizzutti, Susan L Rossell, Dan Siskind, Heidi Taipale, Maxime Taquet, Rachel Upthegrove, Ken Walder, Alison R Yung, Mohammadreza Mohebbi. (2026). GLP-1 receptor agonist initiation and risk of psychiatric hospitalisation and emergency department presentation in adults with schizophrenia and type 2 diabetes in the USA: an observational cohort study using electronic health records data.. The lancet. Psychiatry. DOI: 10.1016/s2215-0366(26)00276-2
Consulta la pubblicazione originale ↗